| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |